613 Pharmacokinetics/pharmacodynamics (PK/PD) of GSK2256098, a Focal Adhesion Kinase (FAK) Inhibitor, in Patients with Advanced Solid TumorsHui Gan, M.J. Millward, Sarah P. Blagden et al.|European Journal of Cancer|2012Cited by 3
354P NUC-3373, a ProTide transformation of 5-FU, in combination with oxaliplatin (NUFOX) or irinotecan (NUFIRI) in patients with advanced colorectal cancer (CRC) (NuTide:302)Andrew L. Coveler, T. R. J. Evans, Aglaia Skolariki et al.|Annals of Oncology|2022Cited by 3
475P A phase Ib study of NUC-3373, a targeted inhibitor of thymidylate synthase, in combination with standard therapies in patients with advanced colorectal cancer (NuTide:302)Jordan Berlin, Sarah P. Blagden, Mary Linton B. Peters et al.|Annals of Oncology|2021Cited by 1